ELVN icon

Enliven Therapeutics
ELVN

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $86.3M invested in Enliven Therapeutics in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.16M
2
+$1.53M
3
+$843K
4
Renaissance Technologies
Renaissance Technologies
New York
+$314K
5
TEE
Tibra Equities Europe
United Kingdom
+$296K

Top Sellers

1
-$2.99M
2
-$704K
3
-$671K
4
Northern Trust
Northern Trust
Illinois
-$657K
5
Two Sigma Investments
Two Sigma Investments
New York
-$430K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$17K
27
$16K
28
$1K
29
$1K
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
1
2